0000000000136707

AUTHOR

Chiara Minà

showing 7 related works from this author

Corrigendum to Patterns of ascending aortic dilatation and predictors of surgical replacement of the aorta: A comparison of bicuspid and tricuspid ao…

2020

The authors regret that the author name of Romano and Raffa are incorrect. The corrected author's name are Romano G and Raffa GM. The authors would like to apologise for any inconvenience caused.

Aortic dilatationAortic valveAortamedicine.medical_specialtybusiness.industrySettore ING-IND/34 - Bioingegneria Industrialeaorta bicuspid aortic valvemedicine.anatomical_structuremedicine.arteryInternal medicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessMolecular Biology
researchProduct

Biomechanical Determinants of Right Ventricular Failure in Pulmonary Hypertension.

2018

Pulmonary hypertension (PH) is a disease characterized by progressive adverse remodeling of the distal pulmonary arteries, resulting in elevated pulmonary vascular resistance and load pressure on the right ventricle (RV), ultimately leading to RV failure. Invasive hemodynamic testing is the gold standard for diagnosing PH and guiding patient therapy. We hypothesized that lumped-parameter and biventricular finite-element (FE) modeling may lead to noninvasive predictions of both PH-related hemodynamic and biomechanical parameters that induce PH. We created patient-specific biventricular FE models that characterize the biomechanical response of the heart and coupled them with a lumped-paramete…

AdultMalemedicine.medical_specialtyHypertension PulmonaryVentricular Dysfunction Right0206 medical engineeringFinite Element AnalysisBiomedical EngineeringBiophysicsCardiac indexHemodynamicsheart failureBioengineering02 engineering and technology030204 cardiovascular system & hematologyBiomaterialsContractility03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansInterventricular septumLead (electronics)business.industryGeneral MedicineMiddle Agedmedicine.disease020601 biomedical engineeringPulmonary hypertensionmedicine.anatomical_structureVentricleVascular resistanceCardiologyFemalebusinessASAIO journal (American Society for Artificial Internal Organs : 1992)
researchProduct

Echocardiography to estimate high filling pressure in patients with heart failure and reduced ejection fraction

2020

Aims: Echocardiographic assessment of left ventricular filling pressures is performed using a multi-parametric algorithm. Unselected sample of patients with heart failure with reduced ejection fraction (HFrEF) patients may demonstrate an indeterminate status of diastolic indices making interpretation challenging. We sought to test improvement in the diagnostic accuracy of standard and strain echocardiography of the left ventricle and left atrium (LA) to estimate a pulmonary capillary wedge pressure (PCWP) > 15 mmHg in patients with HFrEF. Methods and results: Out of 82 consecutive patients, 78 patients were included in the final analysis and right heat catheterization, and echocardiogram…

medicine.medical_specialtyDiastoleHeart failure030204 cardiovascular system & hematologyPulmonary veinVentricular Dysfunction Left03 medical and health sciences0302 clinical medicineInternal medicineFilling pressureHumansMedicineDiseases of the circulatory (Cardiovascular) systemPulmonary Wedge Pressure030212 general & internal medicinePulmonary wedge pressureRight heart catheterismEjection fractionPCWPReceiver operating characteristicbusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeStroke VolumeHFrEFmedicine.diseasemedicine.anatomical_structureVentricleEchocardiographyHeart failureRC666-701CardiologyCardiology and Cardiovascular MedicinebusinessIsovolumic relaxation timeESC Heart Failure
researchProduct

The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fr…

2019

Background: Sacubitril/valsartan has been shown to be superior to enalapril in reducing the risks of death and hospitalization for heart failure (HF). However, knowledge of the impact on cardiac performance remains limited. We sought to evaluate the effects of sacubitril/valsartan on clinical, biochemical and echocardiographic parameters in patients with heart failure and reduced ejection fraction (HFrEF). Methods: Sacubitril/valsartan was administered to 205 HFrEF patients. Results: Among 230 patients (mean age 59 &plusmn

medicine.medical_specialtymedicine.medical_treatmentheart failureHemodynamics030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciences0302 clinical medicinehemodynamicInternal medicinemedicineechocardiography030212 general & internal medicineEnalaprilremodelingEjection fractionbusiness.industryneprilysin inhibitionGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareValsartansacubitril/valsartanHeart failureCardiologyreduced ejection fractionDiureticbusinessNt-ProBNPSacubitril Valsartanmedicine.drugJournal of Clinical Medicine
researchProduct

Patterns of ascending aortic dilatation and predictors of surgical replacement of the aorta: A comparison of bicuspid and tricuspid aortic valve pati…

2019

Abstract Background Predictors of thoracic aorta growth and early cardiac surgery in patients with bicuspid aortic valve are undefined. Our aim was to identify predictors of ascending aorta dilatation and cardiac surgery in patients with bicuspid aortic valve (BAV). Methods Forty-one patients with BAV were compared with 165 patients with tricuspid aortic valve (TAV). All patients had LV EF > 50%, normal LV dimensions, and similar degree of aortic root or ascending aorta dilatation at enrollment. Patients with more than mild aortic stenosis or regurgitation were excluded. A CT-scan was available on 76% of the population, and an echocardiogram was repeated every year for a median time of 4 ye…

0301 basic medicineAortic valveMalemedicine.medical_specialtyBicuspid aortic valveHeart Valve Diseases030204 cardiovascular system & hematologyThoracic aorta03 medical and health sciencesAortic aneurysm0302 clinical medicineBicuspid aortic valveAneurysmBicuspid Aortic Valve DiseaseAneurysm; Bicuspid aortic valve; Echocardiography; Repeated measures; Thoracic aortaInternal medicinemedicine.arterymedicineThoracic aortaHumansMolecular BiologyAortaAgedDyslipidemiasAortaTricuspid valvebusiness.industryAortic Valve StenosisMiddle Agedmedicine.diseaseAneurysmStenosis030104 developmental biologymedicine.anatomical_structureRepeated measureEchocardiographyAortic ValveHypertensioncardiovascular systemCardiologyFemaleTricuspid ValveRepeated measuresCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedDilatation PathologicFollow-Up Studies
researchProduct

Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins

2008

Introduction. Superficial venous thrombosis (SVT) has been considered for a long time a limited clinical condition with a low importance, but this approach has changed in recent years, when several studies demonstrated spreading to deep veins occurring from 7.3 to 44%, with high prevalence of pulmonary embolism . Materials and Methods. To evaluate the prevalence of genetic risk factors for VTE in patients suffering from SVT on both normal and varicose vein, and to evaluate their role on spreading to deep veins, we studied 107 consecutive outpatients with symptomatic SVT. Ultrasound examination was performed, and the presence of FV Leiden, Prothrombin G20210A mutation, MTHFR C677T mutation w…

AdultMalemedicine.medical_specialtyAdolescentDeep veinThrombophiliaGastroenterologyVeinsCohort StudiesVaricose VeinsYoung AdultRisk FactorsInternal medicineVaricose veinsmedicinePrevalenceHumansGenetic Predisposition to DiseaseMethylenetetrahydrofolate Reductase (NADPH2)Venous ThrombosisColor-duplex-Ultrasonography Genetic Risk Factors Superficial Venous Thrombosis Venous ThromboembolismVascular diseasebusiness.industryFactor VHematologyMiddle Agedmedicine.diseaseThrombosisSettore MED/11 - Malattie Dell'Apparato CardiovascolarePulmonary embolismVenous thrombosismedicine.anatomical_structureEmbolismMutationFemaleProthrombinRadiologymedicine.symptombusinessPhlebitisPulmonary Embolism
researchProduct

Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs.

2005

Background. Venous ulcers represent an important medical problem due to their high prevalence and consequent sanitary costs. In this study we evaluated the effect of Prostaglandin E-1 (PGE-1), a drug that improves district ischemia, on the healing of venous ulcers. Methods. We performed a randomized, placebo-controlled, single blind study, in which 87 patients, carriers of venous leg ulcers, homogeneous for dimensions and characteristics, were treated for 20 days an with infusion of Prostaglandin E-1 or placebo, in association with a topic therapy. The dimension and the number of the ulcers were determined at the beginning of the treatment and then every 20 days up to 4 months or until tota…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentVasodilator AgentsIschemiaHealing timeProstaglandinPlacebolaw.inventionVaricose Ulcerchemistry.chemical_compoundRandomized controlled triallawMedicineHumansSingle-Blind MethodAlprostadilAgedLegUltrasonography Doppler DuplexWound Healingbusiness.industryMiddle Agedmedicine.diseasedigestive system diseasesSurgeryClinical trialchemistryBaseline characteristicsVenous ulcers Prostaglandine E-1SurgeryFemaleCardiology and Cardiovascular MedicinebusinessProstaglandin EJournal of vascular surgery
researchProduct